Open Access

Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case report

  • Authors:
    • Yukie Fujita
    • Aya Nakaya
    • Shinya Fujita
    • Masaaki Hotta
    • Hideaki Yoshimura
    • Yoshiko Azuma
    • Takahisa Nakanishi
    • Atsushi Satake
    • Kazuyoshi Ishii
    • Tomoki Ito
    • Shosaku Nomura
  • View Affiliations

  • Published online on: December 7, 2015     https://doi.org/10.3892/mco.2015.695
  • Pages: 151-153
  • Copyright: © Fujita et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Peripheral T-cell lymphoma (PTCL) represents a small heterogeneous group of non-Hodgkin lymphoma (NHL) that accounts for ~10% of NHLs in western countries and ~25% of NHLs in Japan. The disease remains extremely difficult to treat. Therefore, novel treatment modalities are required. Mogamulizumab is a humanized immunoglobulin G1 monoclonal antibody that targets CC chemokine receptor 4. To the best of our knowledge, the efficacy of mogamulizumab in patients who are refractory to conventional chemotherapy following autologous stem cell transplantation has not been investigated previously. The present study reports a patient with PTCL who relapsed following autologous stem cell transplantation and became resistant to salvage chemotherapy, in whom mogamulizumab showed evident efficacy without severe adverse event.
View Figures
View References

Related Articles

Journal Cover

February 2016
Volume 4 Issue 2

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Fujita, Y., Nakaya, A., Fujita, S., Hotta, M., Yoshimura, H., Azuma, Y. ... Nomura, S. (2016). Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case report. Molecular and Clinical Oncology, 4, 151-153. https://doi.org/10.3892/mco.2015.695
MLA
Fujita, Y., Nakaya, A., Fujita, S., Hotta, M., Yoshimura, H., Azuma, Y., Nakanishi, T., Satake, A., Ishii, K., Ito, T., Nomura, S."Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case report". Molecular and Clinical Oncology 4.2 (2016): 151-153.
Chicago
Fujita, Y., Nakaya, A., Fujita, S., Hotta, M., Yoshimura, H., Azuma, Y., Nakanishi, T., Satake, A., Ishii, K., Ito, T., Nomura, S."Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case report". Molecular and Clinical Oncology 4, no. 2 (2016): 151-153. https://doi.org/10.3892/mco.2015.695